Pacific Sage Partners’s Amgen AMGN Stock Holding History

Pacific Sage Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.85M	Sell	5,269 -644	-11%	-$230K	0.29%	35
2025 Q4	$1.94M	Buy	5,913 +533	+10%	+$169K	0.31%	34
2025 Q3	$1.52M	Buy	5,380 +133	+3%	+$38.6K	0.25%	39
2025 Q2	$1.47M	Sell	5,247 -64	-1%	-$18.1K	0.29%	39
2025 Q1	$1.65M	Sell	5,311 -24	-0.4%	-$7.09K	0.37%	35
2024 Q4	$1.39M	Buy	5,335 +1	+0%	+$297	0.32%	37
2024 Q3	$1.72M	Buy	5,334 +1	+0%	+$327	0.41%	31
2024 Q2	$1.67M	Buy	5,333 +8	+0.2%	+$2.35K	0.41%	30
2024 Q1	$1.51M	Sell	5,325 -158	-3%	-$46.2K	0.39%	30
2023 Q4	$1.58M	Hold	5,483	–	–	0.43%	28
2023 Q3	$1.47M	Sell	5,483 -299	-5%	-$74.6K	0.44%	29
2023 Q2	$1.28M	Buy	5,782 +1	+0%	+$232	0.38%	28
2023 Q1	$1.4M	Buy	5,781 +1	+0%	+$245	0.45%	24
2022 Q4	$1.52M	Buy	+5,780	New	+$1.55M	0.5%	25

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Pacific Sage Partners's AMGN Position: Q1 2026 in Review

Pacific Sage Partners reduced its Amgen (AMGN) stake by 11% in Q1 2026, selling an estimated $230K and leaving 5,269 shares worth $1.85M. The position accounts for 0.29% of the portfolio, ranked #35.

Pacific Sage Partners first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.94M in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Pacific Sage Partners held 5,269 shares of Amgen worth $1.85M as of Q1 2026.
Pacific Sage Partners sold 644 Amgen shares in Q1 2026, an estimated $230K.
Amgen made up 0.29% of Pacific Sage Partners's portfolio in Q1 2026, its #35 holding.
Pacific Sage Partners first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
Pacific Sage Partners's Amgen position peaked at $1.94M in Q4 2025.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Pacific Sage Partners's 13F filing for Q1 2026, filed 21 Apr 2026.